Selective solid phase extraction of a drug lead compound using molecularly imprinted polymers prepared by the target analogue approach
- 127 Downloads
Molecularly imprinted polymers have been evaluated at the sample clean-up stage in the analysis of a drug lead compound. In order to circumvent quantification problems related to bleeding of the template, a structurally related analogue of the latter was used. This was selected based on criteria related to interaction site location, solubility, availability and stability of the analogue. Selection of suitable polymerisation conditions was then made using a small batch format (ca. 50 mg) and rapid assessment of binding in the equilibrium mode. It was found that the amount of template could be greatly reduced compared to the conventional protocol, requiring only 5 μmol of template per gram of polymer without seriously compromising the performance of the materials for chromatographic or SPE applications.
Key wordsSolid phase extraction Column liquid chromatography Molecularly imprinted polymers Drug analysis
Unable to display preview. Download preview PDF.
- Sellergren, B. Ed.,Molecularly imprinted Polymers: Man-made mimics of antibodies and their application in analytical chemistry, Elsevier: Amsterdam,2001.Google Scholar
- Barceló, D.,Trends Anal. Chem. 1999,18, 137–137.Google Scholar
- Andersson, L.I.,J. Chromatogr. B 2000,739, 163–173.Google Scholar
- Mayes, A.G.; Lowe, C.R. InDrug development assay approaches including molecular imprinting and biomarkers; Reid, E., Ed.; The Royal Society of Chemistry: Cambridge1998,226, 28.Google Scholar